Michael Dowling Named America’s Most Influential Health Care Leader

Northwell Health President and CEO Michael Dowling, who championed innovation to combat the COVID-19 pandemic and was just as aggressive toward health equity and gun violence as a public health crisis, has been selected as America’s most influential leader in health care by Modern Healthcare.

The respected industry publication announced its annual list of the “100 Most Influential People in Healthcare” in its December 5 issue, selecting Mr. Dowling No. 1, ahead of national brand leaders from the likes of CVS Health, UnitedHealthcare and Moderna as well as President Joe Biden (9th) and Xavier Becerra, secretary of the U.S. Department of Health and Human Services (11th).

Modern Healthcare’s ranking is determined by peers and the publication’s editors based on leadership and impact. This represents Mr. Dowling’s 16th year on the Modern Healthcare list; he ranked second nationally in 2020 and third last year.

“The past year had been one in which disrupters turned into major players and industry leaders raised their voices to effect change within their organizations and the broader community,” said Mary Ellen Podmolik, editor of Modern Healthcare. “Our 2022 ranking of the ‘100 Most Influential People in Healthcare’ recognizes these individuals who are transforming a major sector of the nation’s economy and are focused on improving care and payment models.”

As leader of New York State’s largest health care provider and private employer, Mr. Michael Dowling guided Northwell Health through the darkest days of the First Wave and then worked to upend health inequalities laid bare by the pandemic. One of those initiatives became reality in 2022 when Northwell Health unveiled its Center for Maternal Health. Its goal is to improve maternal health, particularly in underserved communities, by focusing on the continuum of care while addressing health conditions that can occur from pre-conception through the first year after delivery.

“This remarkable recognition truly is a reflection of the collaboration and work ethic elicited by thousands of Northwell team members who deliver compassionate care to our patients each and every day,” said Mr. Dowling. “Of course, our daily focus is on our sickest patients. But to serve our broader community, we also look at health trends both looming on the horizon and lurking under the cover of darkness. That’s why we’ve taken a stand against gun violence. That’s why we’ve opened Northwell’s Center for Maternal Health to reduce maternal mortality, especially among black Americans.”

Northwell has also looked beyond borders to offer aid where it’s needed most. The health system donated supplies to Ukraine – embroiled in an unprovoked war with Russia since February – aligned efforts with Doctors Without Borders and offered telehealth equipment and expert support to aid the frontline.

Finally, Northwell continued its mission of shining a light on gun violence in 2022 by launching an advocacy campaign to ensure that guns in homes with children are locked and out of harm’s way. Northwell launched its Center for Gun Violence Prevention in 2020 on the heels of hosting its first forum on the issue in 2019. Guns are now the No. 1 cause of death among Americans 19 and younger.

To see Modern Healthcare’s Top 100, go to: https://www.modernhealthcare.com/awards/100-most-influential-people-healthcare-2022

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”